| Oct 17 |
Amicus Therapeutics Announces Settlement of Galafold® (migalastat) Patent Litigation with Teva
|
| Oct 14 |
Exploring Three High Growth Tech Stocks in the United States
|
| Oct 14 |
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Is Expected To Breakeven In The Near Future
|
| Oct 9 |
Amicus Therapeutics Inc (FOLD) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and ...
|
| Oct 8 |
Bitcoin-Powered Finance Company Fold, Holding 1000 BTC In Reserves, Moves One Step Closer To Nasdaq Listing
|
| Oct 7 |
JPMorgan Chase & Co's Strategic Reduction in Amicus Therapeutics Inc
|
| Oct 4 |
Amicus Therapeutics Announces Participation at the World Muscle Society Annual Congress 2024
|
| Sep 29 |
'Boring' Amicus Therapeutics Is Making Progress
|
| Sep 25 |
Is Amicus Therapeutics, Inc. (FOLD) the Best Guru Stock To Buy Now?
|
| Sep 6 |
Amicus started at buy by Jefferies, viewed as "growth at reasonable price"
|
